Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Precision Biosciences (DTIL) EPS (Basic) (2018 - 2025)

Precision Biosciences (DTIL) has disclosed EPS (Basic) for 8 consecutive years, with -$1.84 as the latest value for Q3 2025.

  • On a quarterly basis, EPS (Basic) rose 38.67% to -$1.84 in Q3 2025 year-over-year; TTM through Sep 2025 was -$9.0, a 52.54% decrease, with the full-year FY2024 number at $1.05, up 106.58% from a year prior.
  • EPS (Basic) was -$1.84 for Q3 2025 at Precision Biosciences, up from -$2.13 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $4.7 in Q2 2024 to a low of -$24.21 in Q4 2022.
  • A 5-year average of -$2.47 and a median of -$0.8 in 2023 define the central range for EPS (Basic).
  • Peak YoY movement for EPS (Basic): crashed 6271.05% in 2022, then soared 687.5% in 2024.
  • Precision Biosciences' EPS (Basic) stood at -$0.38 in 2021, then plummeted by 6271.05% to -$24.21 in 2022, then skyrocketed by 61.59% to -$9.3 in 2023, then skyrocketed by 69.68% to -$2.82 in 2024, then soared by 34.75% to -$1.84 in 2025.
  • Per Business Quant, the three most recent readings for DTIL's EPS (Basic) are -$1.84 (Q3 2025), -$2.13 (Q2 2025), and -$2.21 (Q1 2025).